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Background: It has been shown that olfactory ensheathing glia (OEG) and Schwann cell (SCs) transplantation are
beneficial as cellular treatments for spinal cord injury (SCI), especially acute and sub-acute time points. In this study,
we transplanted DsRED transduced adult OEG and SCs sub-acutely (14 days) following a T10 moderate spinal cord
contusion injury in the rat. Behaviour was measured by open field (BBB) and horizontal ladder walking tests to
ascertain improvements in locomotor function. Fluorogold staining was injected into the distal spinal cord to
determine the extent of supraspinal and propriospinal axonal sparing/regeneration at 4 months post injection time
point. The purpose of this study was to investigate if OEG and SCs cells injected sub acutely (14 days after injury)
could: (i) improve behavioral outcomes, (ii) induce sparing/regeneration of propriospinal and supraspinal
projections, and (iii) reduce tissue loss.
Results: OEG and SCs transplanted rats showed significant increased locomotion when compared to control injury
only in the open field tests (BBB). However, the ladder walk test did not show statistically significant differences
between treatment and control groups. Fluorogold retrograde tracing showed a statistically significant increase in
the number of supraspinal nuclei projecting into the distal spinal cord in both OEG and SCs transplanted rats. These
included the raphe, reticular and vestibular systems. Further pairwise multiple comparison tests also showed a
statistically significant increase in raphe projecting neurons in OEG transplanted rats when compared to SCs
transplanted animals. Immunohistochemistry of spinal cord sections short term (2 weeks) and long term (4 months)
showed differences in host glial activity, migration and proteoglycan deposits between the two cell types.
Histochemical staining revealed that the volume of tissue remaining at the lesion site had increased in all OEG and
SCs treated groups. Significant tissue sparing was observed at both time points following glial SCs transplantation.
In addition, OEG transplants showed significantly decreased chondroitin proteoglycan synthesis in the lesion site,
suggesting a more CNS tolerant graft.
Conclusions: These results show that transplantation of OEG and SCs in a sub-acute phase can improve anatomical
outcomes after a contusion injury to the spinal cord, by increasing the number of spared/regenerated supraspinal
fibers, reducing cavitation and enhancing tissue integrity. This provides important information on the time window
of glial transplantation for the repair of the spinal cord.
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In models of spinal cord injury (SCI), transplantation of
growth-permissive tissues and cells has been performed
to provide trophic support for damaged neurons and to
transform the inhibitory milieu of the lesion site; this
allows axons to grow through the otherwise impene-
trable glial scar or cystic cavity. Olfactory ensheathing
glia (OEG) facilitate the growth of newly-generated
olfactory sensory axons into the olfactory bulb in normal
adults [1-4] and after olfactory nerve section [5,6].
These cells have the potential to facilitate repair after
injury, and their potential to enhance tissue repair has
been extensively tested in experimental SCI models
[7-14]. Schwann cell (SCs) grafts also have the ability to
promote axonal regeneration following peripheral and
CNS injuries [14-18], and as such were used in this
study to compare the outcomes achieved using OEG in
sub-acute spinal cord injury model.
Standard methods for isolating adult rat and human SCs
have been developed, which result in a homogenous popu-
lation of cells with stable characteristics [19-22]. However,
methods to both isolate the OEG and transplant the OEG
vary considerably, as do the experimental results. OEG
display considerable morphological plasticity in vitro,
changing phenotype within hours after changes in culture
conditions [23-26]. Despite this, consistent functional
and anatomical improvements have been obtained using
olfactory bulb-derived p75-purified OEG from adult
inbred rats [8-11,13,27]; results with lamina propria-
derived OEG are less consistent [28-30].
To initially identify transplanted OEG and SCs, im-
munohistochemistry using an antibody to low affinity
nerve growth factor receptor (p75) was used. However this
approach is problematic, because it cannot unequivocally
distinguish between transplanted OEG and SCs from en-
dogenous SCs, which may enter the spinal cord via dorsal
root entry zones or blood vessels [21,31-33]. Detection of
p75 can sometimes be unreliable, as its ligand-binding
domain can be cleaved in vivo and in vitro by endogenous
proteases [34,35]. For this reason, lentiviral ex-vivo pre-
labeling [12,26,36] of OEG and SCs with DSRED-2 was
also used in this study. This allowed the quantification of
surviving grafted cells, the analysis of their distribution
and influence on endogenous spinal cord cells and axons,
and assessment of their impact on matrix deposition and
the host repair process.
We hypothesized that transplants of adult OEG or SCs
may differ in their ability to promote axonal sparing/
regeneration [4,37] and that a delayed transplant at
14 days post injury would improve anatomical and
functional outcomes following a spinal cord contusion.
This experimental study is based on numerous years of
research into both glial types in CNS injuries, includ-
ing the spinal cord. This time point was chosenbecause: (i) it represents a realistic time window de-
liver this type of cellular therapy in a clinical trial. This
time period also gives consideration for time needed to
generate and purify sufficient autologous OEGs for
transplantation into injured patients, stabilization sur-
gery and an optimal time window for best outcomes
[38], (ii) experimental data from previous animal studies
indicate that delayed transplantation may be more
beneficial for cell survival, integration and reduced im-
mune mediated rejection [8,14,20,38-41], and (iii) after
15 days in vivo a significant scar forms that may inhibit
cell integration and axonal regeneration [38]. In support
of this time point, 14 days was the time point chosen
for the recent oligodendrocyte precursor and activated
macrophage clinical trials. It should also be noted that
the term “sparing/regeneration” has been used in relation
to the analysis of axonal growth within this manuscript;
this is because as described previously in a contusion
model study [8] using fluorogold, we cannot truly dis-
tinguish between spared and regenerated axons.
Results
Cell transplantation is associated with improved retention
of tissue at the lesion site
All experimental groups exhibited loss of tissue at the le-
sion site following the initial contusion injury (Figure 1).
Morphological analysis involved measuring the total amount
of residual tissue; this included intact tissue, as well as the
remaining graft and other degenerate/regenerate tissue
that could not be classified as white or grey matter. The
total tissue remaining included degenerate/regenerate
tissue and the cellular trabeculae between cysts, lesion site
and grafted cells. Tissue integrity classification was deter-
mined by Nissl gold myelin staining, which allows distinc-
tion between intact and non-intact tissue containing
macrophages. The extent of the injury/transplant zone
was also identified by the use of GFAP immunostaining,
which allows the area of intact spinal cord versus the
cyst areas to be defined. On the day of transplantation
(i.e. 2 weeks post initial SCI), the total spinal cord tissue
remaining was 88.4±8.0% of uninjured spinal cord and
the amount of remaining intact tissue was 55.4±12.8%
(mean±s.e.m).
Two weeks following cell SCs transplantation (OEG or
SCs), there were no significant differences between groups
in the amount of total tissue (p=0.27), with 72.4±3.7% >
(n=6) of normal in the medium-injected group, 74.6±9.2%
(n=6) in the OEG-transplanted group and 85.1±2.9% (n=6)
in the SCs-transplanted group. Similarly, there were no
significant differences (p=0.25) between groups for in-
tact tissue remaining, which was 29.5±4.6% (n=6) of
normal in the medium-injected group, 38.9±7.7% (n=6)
in the OEG-transplanted group and 41.6±2.3% (n=6) in
the SCs-transplanted group.
Figure 1 Graphic describing the amount of total tissue remaining and intact tissue at the site of the spinal cord contusion injury at
day of transplant 2 weeks and 4 months. Quantification of gold chloride and Nissl stained sagittal sections to measure the amount of intact
tissue and total tissue remaining within each of the experimental groups using Image Pro. (A): Total tissue remaining 2 weeks and 4 months
after cell transplantation. (B): Intact tissue remaining 2 weeks and 4 months after cell transplantation. There was a significant increase (* p<0.05)
in intact tissue found in the OEG and Schwann cell treated groups when compared to medium controls. (C, G): Appearance of spinal cord
lesion site 2 weeks after injury (i.e. day of cell transplantation) (D) Total tissue remaining at 2 weeks after medium injection. (E) Appearance of
spinal cord lesion site 2 weeks after OEG transplantation (4 weeks after injury). (F) Appearance of the spinal cord lesion epicenter 2 weeks after
Schwann cell transplantation (4 weeks after initial injury). (H): Appearance of spinal cord lesion site 4 months after medium injection.
(I) Demonstrates the spinal cord tissue 4 months after OEG transplantation. Note the considerable increased retention of intact tissue and a
reduction in cystic volume when compared to image (H). (J): Injured spinal cord at 4 months after being injected with Schwann cells at the
14 day treatment time point. Note the presence of small microcysts (see black arrow) within the spinal cord parenchyma, but only where the
Schwann cells are present. Scale bar: 200 μm.
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sue in the transplanted groups was found to be signifi-
cantly greater than controls (p=0.028). Total tissue was
46.5±6.2% (n=11) of uninjured spinal cord tissue in the
medium-injected group, 63.1±3.7% (n=11) in the OEG-
transplanted group and 64.1±5.7% (n=11) in the SCs-transplanted group. A significant difference (p=0.028) was
also seen between groups at 4 months in the amount of
intact tissue remaining, which was 26.0±3.9% (n=11) of
normal in the medium-injected group, 39.5±4.1% (n=11)
in the OEG-transplanted group, and 35.1±6.4% in the
SCs-transplanted group (Figure 1A, B).
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Spinal cord sections visualized with Nissl staining
showed good preservation of spinal tissue. Cysts that
were present were frequently small (see Figure 1D,E and
F) and very few in number. As mentioned above, no dif-
ference in tissue survival was noted in any of the
control or transplanted groups (OEG or SCs). Nissl gold
myelin staining at 4 months showed a reduction in
tissue loss, particularly the reduction in cyst volume
and sparing of white and grey matter within the lesion
zone (see Figure 1H,I and J). The presence of round
microcysts was noticeable in the spinal cords of SCs
treated rats, and were present in 2 week and 4 month
spinal cords; neither OEG transplanted rats or control
(medium injected) rats showed these cysts.Figure 2 Photomicrographs representing lentiviral transduced and tr
lentiviral DsRed2. B: Schwann cells in vitro labeled with lentiviral DsRed2
(C) and Schwann cells (D) within the spinal cord lesion site 2 weeks afte
numbers than the OEG. However, OEG are more dispersed through the
Scale bar (C D): 100 μm.Transgene expression, cell dispersal and survival of
transplanted Schwann cells and OEG
Approximately 92% of OEG and 99% of SCs were labeled
in vitro (as a total of all Hoechst 33342 labeled cells)
(Figure 2A and B). OEG or SCs were not previously trans-
duced with self inactivating lentiviral-DSRED-2 vectors.
This vector was found to be non-toxic (data not shown)
and enabled visualization of cytoplasmic spread and cellu-
lar morphology for up to 4 months post-transplantation
into the CNS. DSRED-2’s stability and capacity to track
cells was determined to be as efficient as seen previously
with GFP [12,26,36,42]. DSRED-2 labeled showed no
additional immunological response in vivo when com-
pared to the GFP transgene which may occur with LacZ
[43] or human placental alkaline phosphatase [44].ansplanted OEG and Schwann cells. A: OEG in vitro labeled with
. Scale bar (A B): 50 μm. C D: Localization of transplanted OEG
r transplantation. Schwann cells appear to have survived in greater
spinal cord tissue while Schwann cells remain in a dense aggregate.
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sagittal sections with OEG and SCs grafts 2 weeks
following cell transplantation. Lentiviral-DSRED-2 labeled
OEG was detected in all but one of the animals whereas
lentiviral-DSRED-2 labeled SCs was detected in all ani-
mals. At 2 weeks after transplantation to the injured spinal
cord, DSRED-2 fluorescence pixel intensity for surviving
transplanted OEG was 70±29 at the rostral aspects of the
transplant/lesion zone, versus 91±37 for SCs, at the center
of the lesion 86±35 for OEG and 100±41 for SCs. Lastly
the DSRED-2 fluorescence pixel intensity at the caudal
edge of the transplant/lesion was 83±34 for OEG and
79±32 for SCs. In rats at 2 weeks (n=6 per group) ana-
lyzed, detectable transplanted OEG had in some cases
dispersed up to 5 mm from the center of the injection site,
the furthest distance measured. In contrast, DSRED-2
positive transplanted SCs were highly localized to the site
of injection, dispersing no more than 0.6 mm from the in-
jection site. At 2 weeks post transplantation the surviving
OEG were dispersed throughout the lesion site and adja-
cent spinal cord tissue, and were aligned along the rostro-
caudal axis of the spinal cord. SCs were densely packed,
with an alignment that was highly regular within the graft
area but did not disperse into the intact host CNS tissue
surrounding the lesion site.
Four months after OEG transplantation, DSRED-2
positive OEG were detected in 7 out of 11 animals
(64%) whereas DSRED-2 positive SCs were detected in
11 out of 11 animals (100%). Measurements of DSRED-
2 fluorescence pixel intensity showed OEG at the rostral
part of the lesion at 22±9 and SCs 34±14, at the center of
the lesion the values were 21±9 for OEG and 29±12 for
SCs. DSRED-2 pixel fluorescence was found to be 19±8
for OEG at the caudal part of the lesion and 28±12 for
SCs. As estimated from the DSRED-2 fluorescence, the
levels of OEG present within the spinal cord had
decreased throughout the rostral-caudal axis of the lesion
by 74% at 4 months from the value seen at 2 weeks post
transplantation. At the same time DSRED-2 fluorescence
pixel values for SCs reduced from 2 weeks and 4 months,
however fluorescence levels were significantly higher than
OEG levels (p<0.05) (see Additional file 1: Table S1).
Scar formation, CS56 synthesis and gliosis
Deposition of proteoglycan scar/inhibitory molecules was
assessed in transplanted OEG, SCs, and control medium
injected spinal cords by immunofluorescence section
staining with antibodies to GFAP and CS56 (for chondro-
itin sulphate proteoglycans). The extent of staining was
assessed across the lesion site in a rostro-caudal direction.
After 2 weeks post transplantation, OEG spinal cords
showed a moderate change in GFAP staining when
compared to SCs and medium treated spinal cords (n=6
(Figure 3A,C). In particular, this was noted at the caudalaspect of the transplant zone (Figure 3B,D). At 4 months
following OEG, SCs and medium injections, GFAP im-
munofluorescence staining (analyzed by pixel intensity)
revealed a trend towards a lower degree of GFAP immuno-
fluorescence at the injury zone. The OEG transplanted
group showed a reduction of 27% in GFAP immuno-
fluorescence when compared to the SCs transplanted
group and a 23% reduction in GFAP immunofluorescence
when compared to the medium-injected group. However,
this difference was not statistically significant (p<0.05).
Integration of transplanted cells with host astrocytes was
frequent for the OEG transplant groups but infrequent for
the SCs transplant animals. CS56 proteoglycan staining
was analyzed across the OEG, SCs and medium groups in
the 4 month post transplant spinal cords (n=11). Immuno-
fluorescence staining for CS56 in the SCs transplanted
group (Figure 3E) was significantly greater than medium
injected control sections (p<0.001) (Figure 3F) and the
CS56 immunofluorescence was greater in the SCs
group compared to the OEG transplanted group (p<0.01)
(Figure 3F). CS56 immunofluorescence in the OEG group
was not significantly different from the levels seen in the
medium injected controls.
Extracellular matrix deposition within the lesion site
At 4 months post injury, the grey and white matter
bordering the lesion site contained numerous blood
vessels, the walls of which were highlighted by laminin-1
staining (Figure 4A,B,D-K). The dura mater was strongly
immunoreactive for laminin-1 in all analyzed spinal cords.
In addition to the meningeal and vascular-associated
laminin-1, the graft sites of OEG and SCs grafts also
contained laminin-1. Compared to the medium injected
control group, the laminin-1-stained area appeared more
extensive in both the OEG and SCs transplanted groups,
but these differences were not statistically significant
(p=0.15). At higher magnification, it was observed that
areas strongly immunoreactive for laminin-1 co-existed
with the DSRED-2 positive cells only in the SCs
transplanted group (see Figure 4I,J,K vs. E,F,G). Frequently,
the areas of strong laminin-1 immunoreactivity in OEG
grafted spinal cords were not associated with the location
of surviving DSRED-2 positive transplanted cells, indicat-
ing another source or cell type such as endothelial cells for
the laminin-1. Laminin-1-positive structures around bun-
dles of axons in both the OEG and SCs transplanted
groups were observed.
The profile of immunoreactivity for collagen IV
(Figure 4C and L-S) was similar to that observed for
laminin-1. Structures resembling blood vessels were
visible around the site of the spinal cord lesion in the
OEG transplanted group (Figure 4L). While the graft
site of the OEG transplanted group contained more
collagen IV immunofluorescence than that of the other
Figure 3 Glial scar formation at the lesion site indicated by GFAP and CSPG immunoreactivity. A-D: GFAP in green DsRed2-labeled
transplanted cells in red. A-B: Lesion site 2 weeks after transplantation of OEG. C-D: Lesion site 2 weeks after transplantation of Schwann cells.
Dispersal of transplanted cells is greater for OEG than for Schwann cells. Schwann cells remain in a dense aggregate at the lesion site surrounded
by strong GFAP immunoreactivity. E: Schwann cells are surrounded by dense proteoglycan network CSPG (green), DsRed2-labeled transplanted
cells (red). Scale bars: A-D: 100 μm, E: 200 μm. F: Graph showing the quantitative fluorescence (measured by mean pixels) of GFAP and CSPG at
the distal interface of the transplant zone (n=10 for each group). OEG had significantly less (p<0.05) CSPG expression when compared to
Schwann cells (see *). Schwann cells had significantly greater (p< 0.05) CSPG expression when compared to medium injected controls (see #).
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pixel intensity revealed the collagen IV immunofluor-
escence for each group to be statistically similar (p=0.10).
As with laminin-1, at higher magnification, collagen IV
could be seen in high quantities in regions of the SCs
grafts. However in the OEG transplanted group high
amounts of collagen IV appeared to originate from
DSRED-2 negative cells in the vicinity of the DSRED-2
positive cells (Figure 4O,S), which may represent either
endogenous SCs invading from the periphery or host
endothelial cells.
Axonal profiles inside lesion site
Immunohistochemistry with the neurofilament-specific
antibody RT-97 was used to estimate the presence of
medium and high neurofilament-containing axons in
and around the lesion site of all transplanted groups and
controls (Figure 5). At the lesion epicenter of all groups,
continuous white matter tracts of spared axons could be
seen at the ventral edges of each section (Figure 5A,B,
and D). Dorsal white matter tracts were in an improvedstate of preservation after OEG and SCs transplants. In
addition, RT97+ axons were present in the lesion site in all
transplanted and control groups with RT97+ axons being
co-extensive with DSRED-2 OEG and SCs (Figure 5E).
Axons entering SCs graft areas or putative graft areas,
were commonly observed to lose rostral-caudal direc-
tionality and instead aligned with the random internal
organization of the graft (Figure 5E). However this non-
linear pathway for axons was not seen in the OEG
transplanted spinal cords (Figure 5C).
Evidence for infiltration of endogenous Schwann cells
into the spinal cord
In several of the OEG or SCs transplanted animals, the
lesion site contained numerous fascicles of cells with
glial-like spindle-shaped morphology; these cells were
positive for p75 but negative for DSRED-2. Sections from
the medium-injected group also contained p75-positive
cells both at 2 weeks and 4 months after transplant
day (Figure 6A,B). The p75-positive cells in the OEG
(Figure 6C and D) and SCs (Figure 6E,F) transplant
Figure 4 Schwann cell, OEG and medium treated spinal cords at 4 months. Photomicrographs depicting the distribution and
immunoreactivity for laminin-1 (A, B, D-K) and collagen IV (C, L-S) at the site of spinal cord contusion lesion with or without the transplantation
of SCs and OEG. Areas of strong immunoreactivity for laminin can be seen to surround the areas of the transplanted cells (see arrow in D
depicting DsRed-2 OEG). Laminin immunostaining does not appear to be co-localized on the surface of the OEG cells (see arrows in G). Laminin
is also found surrounding Schwann cell transplants (see H). Arrow depicts the central core of the transplant. Laminin is very strong in the region
of the Schwann cells (see I-J) with the host spinal cord below the dashed line has reduced intensity of staining. Collagen IV immunostaining
depicts a central core of staining close to the lesion site surrounding any surviving OEG (see L) but labeled cells (see arrows in O) are not co-
labeled with collagen IV. Collagen IV immunostaining in Schwann cell transplanted spinal cords show intense staining surrounding and within
the DsRed-2 SC transplant area (see arrow). In higher power the staining is mostly co-localized (see above dashed line) but some areas are not.
Scale bars: 100 μm. Scale bar in A also serves C, D, H, L and P. Scale bar in B also serves E, F, I, J, M, N, Q and R.
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expressing the DSRED-2 transgene. It is also possible
that SCs had migrated into the spinal cord from blood
vessels within the spinal cord or via the dorsal roots
[45]. The latter is more likely, because the method
using lentiviral vectors encoding transgene such as
GFP have previously been shown to display long termexpression [12] and these p75-positive cells were also
detected in the medium-injected groups.
Numbers of retrogradely labeled descending axons
increased by glial transplantation
Retrograde labeling with Fluorogold was used to quantify
extension of spared/regenerated descending supraspinal
Figure 5 Axonal staining at the lesion site of Schwann cell, OEG and medium groups. Immunoreactivity for RT-97 at the site of spinal cord
contusion 4 months after medium (A) OEG (B-C) and Schwann cells (D-E) transplantation. RT97 positive axons are observed within the lesion
site in all groups but number and distribution varied. Axons in the OEG group (B) were arranged in fascicular bundles but did not have rostral
to caudal orientation unlike axons beneath the graft area which constitute the ventral white matter. See (C) for higher power image of
(B). RT97 staining after Schwann cell transplantation (see D). These axons showed a close association with DsRed-2 positive cells but followed a
non linear path. Arrows in (E) depict DsRed-2 labeled Schwann cells deep within the transplants or close to microcysts (*). Scale bars: 100 μm.
Scale bar in D also serves A and B scale bar in E also serves C.
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the contusion site. Mean±standard errors of numbers
of descending Fluorogold-labeled cells are presented.
There were statistically significant differences (p<0.05)
between the total brain counts of the OEG transplanted
group (3019±216) and also the SCs transplanted group
(2767±411) when compared to the control injury only
group (1204±331).
Statistical differences (p<0.05) were seen in a number of
separate brain regions projecting distally through the
injury zone. OEG transplanted rats showed statistically
significant differences in the Raphe projecting neurons
(562±43) compared to controls (184±62). Numbers of
Fluorogold neurons in the Raphe for SCs transplanted rats
(296±50) did not show significant differences when com-
pared to control injuries only. Rubrospinal Fluorogold
numbers in the OEG and SCs grafted groups were similar
(243±34 and 244±50 respectively) and not statistically
significantly different from the control injury only group
(115±42). The numbers of Fluorogold labeled neurons inthe hypothalamus were significantly higher in both the
OEG and SCs groups (135±16 and 116±23 respectively)
when compared to controls (60±15). Fluorogold labeled
neurons in the reticular formation in control injury only
rats numbered 632±165, as compared to 1590±100 for
OEG treated rats and 1635±23 for SCs grafted animals
(Table 1 and Figure 7). Fluorogold numbers in the
trigeminal/DC were not statistically significantly different
in all groups (Table 1 and Figure 7). This was also the case
for corticospinal layer V neurons whose axons rarely seen
to project into the distal spinal cord (8 mm) fluorogold
injection site (Figure 7). Finally, neurons labeled in the
vestibular system were significantly increased in the OEG
and SCs transplanted rats (373±65 and 360±51 respect-
ively) when compared to control injury only rats (117±27).
Schwann and OEG cell grafts increase the number of
spared/regenerated propriospinal neurons
Fluorogold propriospinal neurons were counted from
spinal cord segments rostral to the lesion/transplantation
Figure 6 Photomicrographs depicting p75 immunoreactivity of spinal cord sections in the lesion site after SCI. Endogenous p75 positive
cells Schwann cells are present within the lesion site 2 weeks (A) and 4 months post injury (B). p75 positive profiles are present in large numbers in
OEG (C-D) and Schwann cell (E-F) transplanted groups. The arrows in C and D represent DsRED-2 positive transplanted OEG within the lesion site co-
mingled with host p75 positive Schwann cells. In the Schwann cell transplanted group the p75 positive endogenous Schwann cells (see arrows) also
surround the transplanted DsRed-2 positive cells The Schwann cell transplants are tightly clustered unlike the dispersed OEG (see C-D). Scale bar in
C (100 μm) also serves A and B.
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rons that had reached the caudal injected Fluorogold
(8 mm caudal from the caudal borders of the injury
site) numbered 6±3 in the medium injected group
38±26 in the OEG transplanted group and 131±59 in
the SCs transplanted group (see Figure 8B). As seen in
Figure 8 there was a significant difference between the
medium injected and OEG transplanted groups, but a
significantly larger number of labeled propriospinal
neurons was observed in the SCs group as compared to
the medium injected group (p<0.03). There was nostatistically significant difference between the OEG and
SCs transplanted groups.
Functional recovery: open field behavioral testing (BBB)
and Ladder walk testing
At two weeks after injury and again at two weeks after
transplantation, rats in all groups had regained bladder
function. Open field behavioral scoring indicated no
statistically significant changes in the BBB scores in all
groups before transplantation (Figure 9). One week
following transplantation of OEG or SCs (i.e. 21 days

























1204±331 632±165 53 60±15 5 117±27 10 184±62 15 115±42 10 88±30 7
Medium
only#
1068±79 624±62 58 53±6 5 113±12 11 134±15 13 75±15 7 64±11 6
OEG
treatment
3019±216# 1590±100# 53 135±16# 4 373±65# 12 562±43# 19 243±34 8 106±17 4
SC treatment 2767±411# 1635±23# 59 116±23# 4 360±51# 13 296±50 11 244±50 9 106±26 4
*The contusion only groups received a moderate contusion injury. Fourteen days after injury, OEG or Schwann cells were transplanted into the lesion site; controls received an injection of cell culture medium. Data are
presented as means ± SEM.
















































































































































































































































Figure 7 (See legend on next page.)
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(See figure on previous page.)
Figure 7 Number of neurons in brain/brainstem nuclei retrogradely labeled with Fluorogold injected 8 mm caudal to the thoracic
spinal cord lesion site. OEG transplantation into the contused spinal cord 14 days after injury promotes significant axonal sparing/regeneration
of Raphe-, Vestibular- and Reticulo-spinal axons. Graphs depict the mean numbers of total FG-labeled neurons in the brains and brainstems of
the four groups (A). Mean neuron numbers of the Raphe (B), Rubrospinal (C), Hypothalamic (D), Reticular (E), Trigeminal/DC (F), Cortical layer V
(G) and Vestibular (H). Experimental groups were compared using a one-way analysis of variance (ANOVA), followed by the Dunnett’s method of
multiple comparisons versus a single control group (injury only) and also the Tukey test for multiple comparison procedures between all
experimental and control groups.
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http://www.biomedcentral.com/1471-2202/14/106post injury) these scores did not increase above control
scores, with all groups scoring 10–11. At 2 weeks after
treatment with cells or medium, control injury only rats
scored a mean of 11, medium injected scored 10, OEG
scored 12 and SCs scored 11 (Figure 9). Three weeks
following injection of cells, the mean BBB scores for
OEG injected rats were 13, SCs scored 12, medium
injected scored 10 and injury only scored 11. Theses
scores were consistent for all the following time points
until day 133 and 144 when OEG scored a mean of 14,
SCs scored 13, medium injected scored 11 and 10, and







Figure 8 Propriospinal neurons rostral to the lesion site were retrogr
lesion site (A). Significantly higher numbers of propriospinal neurons (n=1
and OEG-transplanted groups (*) relative to the medium-injected group (BAfter one week of testing on the BBB score the rats
were introduced to the ladder walk (see Figure 10A). At
6 weeks or 4 months after treatment, most rats scored
between 3.5 and 5.5 (see Table 2) out of 6 on the horizon-
tal ladder walking test (Figure 10B-C), with no significant
differences observed between groups.
Discussion
We have shown the capacity of purified, primary OEG
and SCs to promote behavioral recovery, increase num-
bers of supraspinal axons, and increase tissue sparing
when transplanted two weeks after a moderate spinal8mm
Fluorogold injected 8mm
distal to lesion site cells 
#
adely labeled with Fluorogold injected caudal (8 mm) to the
0, p<0.05) were observed in the Schwann cell-transplanted group (#)
).
Figure 9 Mean BBB scores over 4 months after injection of medium, Schwann cells and OEG plotted against contusion injury only. The red
dotted line depicts the transplant day. A statistically significant increase in BBB scores was seen in the Schwann cell group when compared to
contusion only (#, p<0.05). A significant increase in BBB scores was also seen in the OEG group when compared to control injury only (*, p<0.05).
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DSRED-2 was used to transduce OEG and SCs – in this
study it was shown to be an effective and stable trans-
gene to label both cell types up to 4 months in vivo
following transplantation. Viable transplanted OEG and
SCs were found in similar numbers at 2 weeks, but after
4 months the OEG numbers were less than the number
of SCs remaining. Histochemical tissue analysis showed
a significant reduction in tissue loss in both the OEG
and SCs groups 4 months post-transplantation. Further,
dorsal white matter tracts appeared to be better protected
in the transplant groups than in non-cellular transplanted
controls (medium). Analysis of DSRED-2 labeled glia in
the spinal cords showed a migration/dispersal difference
between the two cell types. OEG were more evenly distrib-
uted in a rostro-caudal direction, and greater integration
of OEG with host astrocytes was evident when compared
to the tight interwoven grafts in the SCs transplanted rats.
OEG transplanted rats displayed significantly lower levels
of CS56 immunofluorescence within and around the
lesion/transplant site when compared to the SCs group.
Matrix deposition was similar between OEG and SCs
groups, but laminin and collagen IV immunofluorescence
showed a closer co-existence of these matrix molecules to
SCs than to OEG. Axonal staining using neurofilament
antibodies showed tighter bundles of axons within the SCs
transplant zone than in OEG zones. Open field behavioral
testing (BBB) showed significant differences between
the transplanted groups and the controls up to 4 months
after transplantation. BBB scores were consistently
higher in the OEG group compared to control injury,
medium and SCs injected rats. Additional behavioraltesting using the ladder walk however, did not show any
significant differences between experimental and con-
trol groups. Fluorogold retrograde tracing 8 mm distal
to the injury/transplantation site revealed significant
differences between control groups and OEG and SCs
transplanted groups in supraspinal projecting axon pop-
ulations. This provides strong evidence that a sub-acute
transplant of SCs or OEG provide an environment in
which promotion of sparing/regeneration of supraspinal
axonal projections to the spinal cord are increased.
SCs and OEG differ in their interaction with host spinal
cord cells and matrix production.
Evidence of statistically significant tissue-protective effects
of OEG was observed 4 months after transplantation. At
2 weeks post-transplantation, tissue loss was still occur-
ring. The tissue-protective effects of transplanted OEG
or SCs arise from the secretion of factors from the cells
such as BDNF, NGF, GDNF and NT4/5 [13,46-48] or
matrix (laminin-1, collagen IV) and adhesion molecule
(N-Cadherin) secretion [49-51]. These mechanisms of
protection combined with tissue-rebuilding or new cell
birth [52], are potentially acting together to improve
anatomical functional outcomes.
Proliferation of donor OEG seems unlikely, as the
labeling method employed in this study would result in
all daughter cells also being labeled; the number of
labeled cells at 4 months in the lesion site were fewer
than when counted at 2 weeks. The fewer numbers of
detectable OEG involves movement away from the site
of injury (measurement area), or death (via apoptotic or
anoikis mechanisms) [42,44]. In a small number of
Figure 10 Ladder walking behavioral testing. A: representative photo of a rat traversing the horizontal ladder. B: ladder scores of treatment
groups on horizontal ladder walking test 6 weeks after cell transplantation date. C: as for B at 4 months after cell transplantation date. At no
stage were statistical differences between groups observed on the horizontal ladder test.
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the injection site which is similar to earlier studies
which reported OEG migration at distances of 9 mm
from the injection site [9,53,54]. In contrast to the OEG,
SCs were not observed very far from the immediate
lesion area, dispersing only up to a distance of 1.5 mm.
A similar lack of dispersal has been reported out of per-
ipheral nerve grafts inserted into the adult CNS [55,56].
This is likely due to interactions with host astrocytes
and other endogenous non-neuronal cells [57].
The observed difference in the amount of intact tissue
between the OEG and SCs transplanted groups indicates
chemotropic effects of the OEG [58], similar to the
chemotropic effects exerted by glia during development[59] that result in increased infiltration of various cells
into the lesion site. OEG have the capacity to stimulate a
different inflammatory response by the secretion of
chemokines such as CX3CL1 [60], which is a known
ligand for the receptor CX3CR1 found on microglia and
dendritic cells [60,61] and affects the amount of tissue
preservation/removal. OEG potentially are be more sus-
ceptible to death and subsequent phagocytosis by macro-
phages than SCs. OEG are known to secrete different
factors and have unique antigenic profiles other than the
ones mentioned above which make them more susceptible
to immune attack [62].
OEG and SCs transplants have the properties to directly
influence proliferation or differentiation of spinal cord
Table 2 Scoring scale developed for the ladder rung




Deep slip then jump 1
Deep slip, unsuccessful or no paw replacement 1
Deep slip, paw replacement, slight slip 2
Step, unsuccessful paw replacement 2
Deep slip, successful paw replacement 3
Jump step 3
Step, paw replacement, slight slip 4
Step, good paw replacement 4
Slight slip, short stride 5
Slight slip, regular stride 5
Plantar paw placement, short stride 6
Plantar paw placement, regular stride 6
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the potential to differentiate these stem cells, like fibro-
blasts [64], into neurons or myelinating glia [64-67]. In
our study we did not examine the direct OEG or SCs mye-
lination potential or host myelination within the lesion
site. Both cell types have the capacity to myelinate but dif-
fer in their effectiveness and mechanisms involved [75,
Plant et al., -unpublished observations]. The proliferation
of endogenous cells does occur in SCI [45]. These cells
can include progenitor cells, endothelial and pericytes
stimulated by factors such as epidermal growth factor
and/or fibroblast growth factor-2 [68-70]. Proliferation
seems highly plausible especially when OEG and SCs are
known to produce similar levels of FGF-2 [71]. Two recent
findings have indicated new cells play a role in SCI. New
evidence from Goritz and colleagues [72] has indicated
that pericytes play a role in the spinal cord injury
response, whereby these cells actively migrate to sites of
injury. OEG and SCs in our model are likely to have
altered the number of these cells in the lesion site, thus
providing a reparative outcome. In addition, evidence by
Decimo and colleagues [73] found new adult stem cell /pre-
cursor cells that are resident in the meninges react to SCI
and populate the injury site, thus providing a target for glial
cell differentiation or activation.
In this study we provide evidence that following spinal
cord contusion injury, endogenous repair processes
including SCs migration were ongoing. Proliferation of
ependymal cells in the walls of the central canal and
from adjacent intact parts of spinal cord [45,52,65,74,75]
is one route. Ependymal cells are known to migrate and
populate the lesion site along with new blood vessels,
astrocytes and fibroblasts. This seems likely to havecontributed to the cellular trabeculae and scar tissue seen
within our lesion cysts [45,75,76]. Host SCs from the
dorsal roots or blood vessels also infiltrated the lesion site
in our model, based on large numbers of p75-positive/
DSRED-2 negative cells in all groups, as has previously
been observed in the rat [14,45,55,77,78] and human [79]
with the majority from the dorsal roots [32].
In a previous study from our laboratory [57], we
indicated that molecules (including neurotrophins)
released by Schwann cells promote the reactivity of
astrocytes. Transplanted SCs stimulate astrocytes to be
highly GFAP positive and surrounded by CS56 staining.
This forms a dense glial scar around the lesion and pre-
vents the entry of axons, and/or other host non-neuronal
cells [57]. In this study we demonstrate in sub-acute 14 day
glial transplants, OEG were associated with significantly
lower CS56 expression and slightly higher collagen IV
expression in the lesion and graft site compared to SCs.
Since OEG are proficient in interacting with astrocytes
in vitro [49,80], their release of extracellular matrix and cell
adhesion molecules and their modulation of these factors
may also account for the observed axonal infiltration into
the glial scar [81]. Molecules such as Fibulin-3 and its abil-
ity to bind TIMP-3 may also play a part in the different
interaction with host glia [26]. OEG isolated from the olfac-
tory bulb show high levels of this protein when compared
to SCs [26]. One recent report has also suggested an im-
portant role of MMP’s in cell migration and modulation of
the ECM [82]. While both OEG and SCs appeared to be
associated with a greater quantity of extracellular matrix
molecules in the lesion site compared to the effect of
medium injection alone, their profiles differed. The lam-
inin was present in a complementary and non-
overlapping pattern to DSRED-2 labeled SCs and OEG.
SCs appeared to produce basement membrane, while
OEG are capable of producing these molecules but not
in the quantity seen in SCs grafted animals; rather, they
may have induced other cells to produce extracellular
matrix such as astrocytes or endothelial cells. This is
not surprising given the role the OEG play in the olfac-
tory system, where OEG form channels which stay
present even after axonal degeneration in the olfactory
bulb for axons to grow through and out to innervate
areas of the olfactory bulb [83,84]. One mechanism for
OEG reparative outcomes in the CNS is their close “cross-
talking” with fibroblasts/meningeal cells [see 48,81] and
ability to interact with these cells [9,85]. OEGs have
a very close relationship with fibroblasts in the olfac-
tory system, as do SCs in the peripheral nerve, but
their role seems very different. SCs are potentiated
to myelinate axons by fibroblasts and their associ-
ated matrix [86], whereas OEG interact in an axonal
replacement/regenerating system without myelination
[87]. In addition they have previously been shown
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fibroblasts [88-90].Olfactory glia and Schwann cells increase axonal sparing/
regeneration in sub acute treated SCI
Our results show that transplantation of OEG or SCs at
2 weeks after contusion facilitated significant axonal spar-
ing/regeneration comparable to those seen in transplants
carried out 7 days after a contusion injury [33]. Significant
increases in regenerated propriospinal fibers were also
present in both graft groups, but numbers in SCs treated
animals were significantly higher than after OEG trans-
plantation. This indicates a more potent, local secretion of
factors by SCs compared to OEG, but as yet no study
has extensively analyzed these differences. In this study,
an OEG or SCs transplantation following a contusion
injury was associated with an increased amount of
intact tissue at the lesion site. Immunohistochemistry
for neurofilament-positive axons showed strongly immu-
noreactive profiles at the lesion site for both OEG and SCs
transplanted groups after a 14 day delay of transplantation.
Neurofilament positive axons in the SCs group were less
linearly organized than those seen in the OEG group. This
could be explained by the interaction with host astrocytes
not allowing for the even distribution of the cells and the
formation of a clear cellular boundary [91].
Retrograde tracing using Fluorogold revealed statistically
significant increased numbers for supraspinal tracts after
OEG or SCs transplantation. Supraspinal spinal tracts
such as reticular, vestibular and hypothalamic were seen
to respond similarly in both transplant groups. It should
be noted that these supraspinal fibers were measured from
8 mm distal to the injury site, and so possible differences
in fiber numbers between the transplanted cell groups at
the lesion site itself cannot be discounted. Unlike the other
spinal tracts, the raphe tract responded in a far more ro-
bust fashion in the OEG group. This can be via increased
responsiveness to BDNF from the OEG directly or by the
interaction with activated microglia which are known to
secrete BDNF after ATP activation through the P2X4 re-
ceptor [92]. OEG differ to SCs in their levels of fractalkine
secretion, and this can activate microglia to become more
active and secrete different neurotrophic profiles to that
initiated by SCs that do not secrete this protein at the
same level. An important consideration, that is difficult to
assess at the time of cell delivery, is the stage of cellular
differentiation of transplanted glia after a period of time
in vivo. SCs will differentiate into myelin forming cells
quite quickly thus reducing their regenerative/autocrine
secretory products [93-95] whereas OEG stay in an undif-
ferentiated [p75-positive) non-myelin forming state for a
longer periods (Plant – unpublished observations) or may
not myelinate at all [33].Functional recovery is improved after sub acute
transplantation of OEG and SCs
Significant behavioral differences were observed be-
tween the control injury and medium injected rats, and
both OEG and SCs grafted groups. Improvements,
which are normally observed in studies similar to that
undertaken here, may result from compensatory effects
occurring within reflex-based segmental cord systems
[96]. OEG transplantation into a completely transected
spinal cord has elicited improved hindlimb function
[9,10,97] as seen here. One possibility that could increase
locomotion is increased noradrenergic and serotonergic
varicosities apposing the motor associated cholinergic
neurons [98]. OEG treated rats showed significant num-
bers of raphe projecting axons reaching at least 8 mm
distal from the injury site and these could stimulate such a
behavioral response. This however does not explain the
SCs grafted rats which may use an alternate but effective
pathway of locomotion. SCs induced recovery could be
partially explained by a graft relay system developed
through regeneration of propriospinal axons regeneration
as seen in our results here. Only small numbers of spared
fibers (<5%) are required to facilitate compensatory return
of function via segmental circuits [99]. Phasic behavioral
recovery in the SCs group, in particular 49 days until the
end of the experiment, may be due to phasic secretion of
neurotrophins which may not be delivered at the same
level via the transplantation of OEG.
Conclusions
Glial cells transplanted at 14 days post injury may experi-
ence a less accommodating lesion site than when grafted
1 week after injury, which may explain a reduced glial sur-
vival in particular for OEG than seen in earlier transplant
studies. At 14 days post SCI proteoglycan deposition at
the lesion site is present and highly inhibitory [100,101]
but was shown to be reduced in the OEG transplanted
groups providing a positive milieu for the sparing/regener-
ation of supraspinal axons (serotonergic positive fibers).
This evidence is strongly backed by our use of fluorogold
tracing, but was not supported by immunohistochemistry
for 5-HT [98] (which labels serotonergic axons innervat-
ing the spinal cord). Supplementation of glial transplants
with neurotrophins may improve cell survivability [13]
and in combination with removal of the glial scar by the
use of chondroitinase could potentially improve axonal
regeneration in this 14 day delayed glial transplant model
[102,103]. Clearly the delay between injury and treatment
can have a strong bearing on the experimental outcome
but also the success of the glial type to improve tissue and
behavioral outcomes, modify the lesion site and improve
sparing/regeneration of axonal populations as shown here.
From the present study it would appear that a 14 day delay
in glial transplantation is feasible and beneficial both
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injury but the mechanisms of repair of the two glial types
are different. We have examined two time points (2 weeks
and 4 months) using multiple behavioral and anatomical
analysis, but results can only give an indication of efficacy.
Further physiological, behavioral and anatomical correla-
tive studies using these glial cells at 14 days post injury
time point would provide valuable evidence of cell poten-
tial and reproducibility for future CNS repair applications.
Methods
Animals
Adult (180-200 g) female Fischer 344 rats (Animal
Resource Centre, Murdoch, Western Australia) were
housed in groups of three under controlled conditions
of temperature and humidity, with free access to food
and water. All procedures were approved by the
Animal Ethics Committee of The University of Western
Australia (approval number 99/008/E42). Fourteen days
after injury, previously described injection procedures [8]
were used to transplant OEG (n=6 short term 2 weeks,
and n=11 long term 4 months) or SCs (n=6 short term
2 weeks and n=11 long term 4 months) into the lesion site
controls received an injection of cell culture medium (n=6
short term 2 weeks and n=11 long term 4 months) or in-
jury alone (n=6 short term 2 weeks and n=11 long term
4 months). Six additional rats were perfused 2 weeks after
contusion without a transplant, to examine the lesion mi-
lieu into which transplanted cells would have been intro-
duced. Total rats used n=74. All rats receiving a transplant
and/or medium were perfused at 2 weeks or 4 months
after transplantation. The numbers of animals were final
numbers analyzed. In the long term groups 3 animals died
and in the short term groups 6 rats.
Olfactory ensheathing glia and Schwann cell culture and
purification
OEG were prepared from the olfactory bulbs of adult
female Fischer 344 rats [8,13,33]. In brief, the bulbs
were extirpated and the olfactory nerve layer dissected.
Tissue was mechanically dissociated and treated with
trypsin 0.5% w/v (Worthington Biochemical Corporation,
Lakewood, NJ) in Hank’s Balanced Saline Solution
(Sigma) for 60 minutes at 37°C in a CO2-free incubator.
Tissue was pelleted by centrifugation at 1500 rpm for
5 minutes, resuspended in DF10S medium (1:1 DMEM/
F-12 -Sigma), 10% (v/v) fetal calf serum - Hunter Antisera)
supplemented with bovine pituitary extract (20 μg/mL
Gibco) and forskolin (2 μM Sigma), then plated on poly-
L-lysine-coated culture dishes (Corning, Acton, MA) for
one week. OEG were purified by immunoaffinity to an
antibody to the p75 receptor (192-IgG) [13,33].
SCs were isolated from adult female Fischer 344 rats
[19,33]. Briefly, the sciatic nerves were dissected, placedin 35 mm uncoated tissue culture dishes in D10S medium
consisting of DMEM (Sigma St Louis, MO) with 10% fetal
calf serum (Hunter Antisera Jesmond, NSW, Australia)
and cut into 1-2 mm3 pieces. Each week, nerve segments
were transferred to a new culture dish, leaving behind
fibroblasts that had migrated out of the explants. After
three weeks of fibroblast depletion, explants were enzy-
matically and mechanically dissociated and transferred to
new dishes for culture in the presence of bovine pituitary
extract (20 μg/mL Gibco, Carlsbad, CA) and forskolin
(2 μM Sigma) [22].
Lentiviral labelling of glia
Lentiviral vectors encoding the gene for DSRED-2 were
made according to methods described by [104]. Cultured
OEG or SCs were labeled by adding the vector (using a
multiplicity of infection of 100 [12] to the culture
medium for 16 hours, followed by 2 washes in culture
medium and fresh media for growth.
Spinal cord injury and post-operative care
Anesthesia was induced with 5% (v/v) halothane (in
60:40 O2:N2O) then maintained at 2-3%. The skin and
muscle layers were cut rostro-caudally to expose the
vertebral column, and a T10 laminectomy performed
[8] Using an New York University (NYU) impactor, a
moderate contusion injury was induced by dropping a
10 g weight from a 12.5 mm height [99,105] Gel-Foam
(Pharmacia & Upjohn, Kalamazoo, MI) was used to stop
bleeding in some animals. Animals were partially suspended
from clamps to the dorsal processes of T8 and T11/12, to
circumvent diaphragm-induced dorso-ventral movement
of the spinal column. Immediately after the injury, the
animal was removed from the clamps and the muscles
sutured in layers with Vicryl (Johnson & Johnson, New
Brunswick, NJ). Skin was closed with Michel suture clips
(Fine Science Tools Inc., North Vancouver, BC, Canada).
Immediately after surgery, each animal was injected with
penicillin (Benacillin intramuscular), analgesic (Temgesic
buprenorphine sub-cutaneous 0.1 mg/kg) and 2-4 mL
0.9% saline (sub-cutaneous). Animal cages were placed
partially onto a heating pad for 24 hours, to assist with
maintenance of body temperature. Antibiotics were con-
tinued on alternate days, with analgesic twice daily and
saline once daily for one week. Manual bladder expression
was performed twice daily for two to three weeks, by
which time all animals had recovered bladder tone.
Cell transplantation
Cells were transplanted after no more than 2 weeks
in vitro [8]. Fourteen days post-contusion, adult female
rats were anesthetized and the spinal cord exposed as
described above. Either 5 μL of a cell suspension containing
5 × 105 OEG or SCs in culture medium, or medium alone,
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the lesion over a period of 3 minutes using a 5 μL syringe
(Hamilton, Reno, NV) mounted in a stereotaxic frame.
The needle was withdrawn 3 minutes later to encourage
cell integration into the injection site. Wounds were
sutured and post-operative care was administered as
described above.
Behavioral testing
All testing of the BBB and ladder walk were carried out by
observers blinded to the treatments. BBB testing [99] was
performed on each animal on the day following contusion,
to confirm the successful lesion (a score of 0). The BBB
test was repeated on day 3, day 7 and day 14 after contu-
sion thereafter every week after cell transplantation.
3 weeks post-injury, animals were consistently scoring
BBB results of 10–11. A ladder rung walking test modified
from [106] was introduced 1 week after injury and mea-
sured every week for 4 months. The ladder rung walking
test provided 6 points (Table 2) for scoring, thus allowing
a greater level of sensitivity than the two BBB points by
which they were separated.
The ladder rung walking test [106] apparatus was 1.5 m
in length and consisted of two clear Perspex sidewalls and
a floor with removable metal rungs spaced 1 cm apart.
Prior to surgery, rats were trained to walk along the ladder
to reach their home cage. From 1 week after injury, trials
were performed weekly and video recorded. The animals
had 3 runs per day when tested. The video camera was
positioned to capture the central portion of the ladder,
approximately 30 cm in length, allowing analysis of
approximately 8 steps of each hind limb. Each hind limb
step in each trial was later scored (Table 2) the scores
were averaged to give a single value, per rat, per trial.
Fluorogold labeling
Ten days prior to perfusion (4 months post-transplantation
of cells), 11 rats from each of the long term (4 month)
groups were anesthetized as above and subjected to a T12
laminectomy. While held in a stereotaxic frame, Fluorogold
(1 μL Fluorochrome Inc., Denver, CO) was injected into the
spinal cord at 4 points (0.25 μL each), 2 segments caudal
(8 mm) to the contusion site. All injections were performed
by the same individual, to maximize comparability between
animals this individual was also blinded as to which groups
had previously been injected with OEG, SCs or control
cells. Muscles were sutured in layers and the skin closed
with Michel suture clips (Fine Science Tools Inc., North
Vancouver, BC, Canada). Animals were treated with the
post-operative care regime detailed above.
Tissue processing
At 2 weeks or 4 months after Schwann cell or OEG
transplantation, rats were terminally anesthetized withNembutal (intraperitoneal sodium pentobarbital Merial
Australia, Parramatta, NSW, Australia) and perfused
intracardially with approximately 150 mL of heparinized
phosphate-buffered saline (Heparin 1 U/mL David Bull
Laboratories, Melbourne, VIC, Australia) followed by
approximately 150 mL 4% buffered paraformaldehyde
solution. The spinal cord and brain were immediately
removed and post-fixed in buffered paraformaldehyde
overnight at 4°C. The following day, paraformaldehyde
was replaced with 0.1 M phosphate buffer. Prior to tis-
sue sectioning, each spinal cord or brain was placed into
sucrose (30% w/v in phosphate buffer) overnight and
embedded in gelatin (10% w/v in phosphate buffer
Difco, Franklin Lakes, NJ). The gelatin block was fixed
by immersion in buffered paraformaldehyde for 2 hours
and placed into buffered sucrose solution overnight.
Tissue was sectioned (spinal cord at 40 μm brain at
50 μm) using a freezing sledge microtome and placed
into phosphate buffer containing 0.05% w/v sodium azide.
Tissue analysis - Quantification
Numbers of animals per group were 8–12 and based on:
(i) a prior power analysis study to ascertain experimen-
tal numbers in animal models of spinal cord injuries, in
order to appropriately assess statistical differences, and
(ii) previous publications from the laboratory. All rats
were tested with BBB, gridwalk, fluorogold traced, im-
munohistochemistry, and tissue analysis. These were
randomly allocated to the groups without the know-
ledge of the surgeon or behaviorist. Animals were taken
from the naïve cages and re-housed into post-surgery
cages and numbered. This number was then combined
by an independent person to identify the treatment. At
every level the person was blinded to the treatment.
The perfusions were performed on the same day for all
groups with the same fixative batch. The immunohisto-
chemistry was also carried out between each of the groups
reducing differences in staining between days and groups.
The analysis was performed by a trained viewer who was
blinded to the groups.
Tissue volume estimation
One in six sections from each spinal cord was mounted
onto gelatin-coated microscope slides and stained with
gold chloride solution for myelin followed by cresyl violet
for Nissl substance [107]. Slides were dehydrated through
an ethanol/toluene series and mounted in DPX (Chem
Supply, Gillman, Australia). Sections were visualized using
a Leica DM RBE microscope and digitally photographed.
Image Pro Plus (Media Cybernetics, Silver Spring, MD)
was used to measure the tissue area of a 4.5 mm section
of spinal cord with the lesion center at its midpoint.
Tissue cavitation was measured in all animals to gain
an estimate of the effect of the transplanted cells upon
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tissue remaining at the injury site was measured in a
similar manner to that described previously [8,14,108]
The combined area of any cysts was calculated and
subtracted from the total tissue area of the section, to
give a value for the total tissue remaining. Areas showing
signs of degeneration, such as microcysts and loss of
neuronal profiles, were subtracted from the values for
total tissue remaining to obtain a measure of intact tissue.
The values for the centre four sections of each spinal cord
were averaged to give a single semi-quantitative value of
remaining tissue volume value for each rat. Values from
four equivalent sections of an uninjured spinal cord were
used to compute the tissue remaining as a proportion of
uninjured spinal cord.Immunohistochemistry
Series of one in six tissue sections (in 2 week or 4 month
time points) were immunostained free-floating with mouse
monoclonal or rabbit polyclonal antibodies. Sections were
incubated overnight at 4°C in primary antibody diluted in
phosphate buffer containing 10% normal goat serum and
0.2% (v/v) Triton X-100. Mouse monoclonal antibodies
used were: i) anti-chondroitin sulfate proteoglycans (CS-56
1:50 Sigma) to identify proteoglycan deposition at the lesion
site, ii) low affinity nerve growth factor receptor p75
(supernatant 192-IgG) to stain for OEG and Schwann cells
(both transplanted and endogenous) and iii) anti medium/
high neurofilaments RT-97 (supernatant Developmental
Hybridoma Bank) to stain for spared and regenerated
axons. Rabbit polyclonal antibodies were used for: i) p75
(1:200 Promega, Madison, WI), Glial fibrillary acidic pro-
tein (GFAP) (1:500 DakoCytomation, Denmark) to stain
for astrocytes, unmyelinated Schwann cells and olfactory
glia, ii) anti-collagen IV (1:200 Rockland Inc., Gilbertsville,
PA) to ascertain the distribution of basal lamina and blood
vessels and iii) anti-laminin-1 (1:200 Sigma) for basal
lamina and blood vessels.
The following day, sections were washed three times
with phosphate buffer and incubated with secondary
antibody (diluted in the same solution as for primary
antibodies) for 30 minutes at room temperature. Sections
were washed three times with phosphate buffer, mounted
onto gelatin-coated glass microscope slides, air dried and
then coverslipped in a glycerol-based mounting medium.Semi-quantitative analysis of proteoglycan, matrix and
cell survival in vivo
One in 6 series of sections at 4 months post transplant-
ation (and controls) were analyzed. Low magnification
photomicrographs (10× objective) were taken using an
IX70 Olympus microscope. Pixel fluorescence of immuno-
staining for CS-56, laminin and collagen IV was measuredat rostral, middle and caudal locations of the contusion/
injury sites and the average pixel fluorescence minus
background readings of the three areas compared be-
tween medium control and OEG or SCs groups [37,57].
In addition, one in 4 series of sections were analyzed for
the presence of DSRED-2 labeled cells in the 2 week
and 4 month survival groups. Pixel fluorescence was
then compared between the 2 survival points to esti-
mate survival of OEG and SCs at 4 months expressed as
a percentage of those present at 2 weeks.Fluorogold photography and counts
A 1 in 6 series of brain sections were mounted onto
gelatin-coated glass microscope slides, air-dried and
mounted in a glycerol-based mounting medium. Sections
were photographed with a Hitachi HV-C20M digital cam-
era as a large tiled image using a fluorescence microscope
(Leica DM RBE) with a motorized stage controlled with
Image Pro Plus (5.1) software (Media Cybernetics). The
optical dissector method was used to photograph and
count fluorogold-labeled neurons, in order to avoid inac-
curacies due to double counting [109] Photographs were
taken in the centre of the z-axis of each section. Those cell
bodies in focus were identified, then tagged and counted
using Image Pro Plus. Seven areas were analyzed: the re-
ticular formation, vestibular nucleus, trigeminal and dorsal
column nuclei, raphe nucleus, red nucleus, hypothalamus
and motor cortex.
To quantify sparing/regeneration of descending proprio-
spinal neurons, the labeled cell bodies were counted using
an identical method in the spinal cord region rostral to
the lesion site. Six spinal cord sections (1 cm in length)
from each animal were analyzed.Statistical analysis
The methods of statistical analysis were chosen that
reflected the animal numbers used in this study. For
Fluorogold labeling of supraspinal projecting nuclei in
the brain, experimental groups were compared using a
one-way analysis of variance (ANOVA) followed by the
Dunnetts methods of multiple comparisons versus a
single control group (injury only) and also the Tukey
test for multiple comparison procedures between all ex-
perimental and control groups. Fluorogold analysis of
propriospinal projections into the distal spinal cord
were analyzed using a one way analysis of variance
(ANOVA). This was also the case for the tissue sparing
and proteoglycan and cell survival analysis. In the ana-
lysis of the BBB scores, groups were compared using the
non parametric Kruskal Wallace ANOVA on ranks.
This was followed by Dunnetts method of multiple
comparisons versus a single control group.
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